Sun Pharma Q2 Review: Brokerages Largely Bullish On Portfolio Growth, Healthy Margins

Citi said Sun's healthy margins should ease investor concerns, while Morgan Stanley highlighted that Sun maintained leadership in India.

Nov 6, 2025 - 10:00
 0  12
Sun Pharma Q2 Review: Brokerages Largely Bullish On Portfolio Growth, Healthy Margins
Citi said Sun's healthy margins should ease investor concerns, while Morgan Stanley highlighted that Sun maintained leadership in India.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow